AUSTRALIAN CLINICAL LABS LTD (ASX: ACL)

ASX: ACL (AUCLINICAL FPO [ACL])

Kemas kini terakhir: 24 Dec, 2024, 11:09PM

0.00 (0.00%)

Tambah ke senarai pantauan

Harga / Pendapatan (P/E TTM)	28.92
Harga / Pendapatan (P/E Ke hadapan)	14.53
Harga / Jualan (P/S)	0.830
Harga / Buku (P/B)	3.54

Arah Aliran Pasaran

		Jangka Pendek	Jangka Sederhana
Industri	Diagnostics & Research (AU)	Bercampur	Bercampur
	Diagnostics & Research (Global)	Menurun	Menurun
Stok	AUCLINICAL FPO [ACL]	-	-

AISkor Stockmoo

0.9

Saham Serupa

Stok	Modal Pasaran	DY	P/E (TTM)	P/B
ACL	696 M	4.24%	28.92	3.54
IDX	847 M	2.56%	114.00	1.23
CAJ	405 M	2.34%	-	3.72
IIQ	48 M	-	-	2.20
CTE	39 M	2.67%	19.88	27.92
BDX	34 M	-	-	3.32

Australian Clinical Labs, or ACL, is Australia’s third-largest private pathology provider. ACL earns almost its entire group revenue from pathology services in Australia, which are mostly earned via the publicly funded health Medicare system. ACL is well-established in the states of Western Australia, South Australia, Victoria and the Northern Territory.
Sektor	Healthcare
Industri	Diagnostics & Research
Gaya Pelaburan	Small Core
% Dimiliki oleh Orang Dalam	3.61%
% Dimiliki oleh Institusi	56.89%

Tiada data dalam julat masa ini.

Portfolio

AI Templat

Peringatan harga anda

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Tiada saham yang memenuhi kriteria anda

Margin Keuntungan	4.21%
Margin Operasi (TTM)	7.40%
EPS Cair (TTM)	0.150
Pertumbuhan Hasil Suku Tahunan (YOY)	9.50%
Pertumbuhan Pendapatan Suku Tahunan (YOY)	136.00%

Jumlah Hutang/Ekuiti (D/E MRQ)	186.45%
Nisbah Semasa (MRQ)	0.590
Aliran Tunai Operasi (OCF TTM)	167.16 M
Aliran Tunai Bebas Leveraj (LFCF TTM)	167.42 M

Pulangan Atas Aset (ROA TTM)	7.11%
Pulangan Atas Ekuiti (ROE TTM)	18.56%